Hypothalamic injection of oxyntomodulin suppresses circulating ghrelin-like immunoreactivity

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3513-3520

  Patterson, Michael ^a   Murphy, Kevin G ^a   Patel, Sejal R ^a   Patel, Neekhil A ^a   Greenwood, Hannah C ^a   Cooke, Jenny H ^a   Campbell, Daniel ^a   Bewick, Gavin A ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN [9 39]; GHRELIN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; HORMONE ANTAGONIST; MESSENGER RNA; OXYNTOMODULIN; PROTEIN C FOS; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; HYPOTHALAMUS; IMMUNOREACTIVITY; LATERAL BRAIN VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; EATING; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GHRELIN; HYPOTHALAMUS; INJECTIONS; INSULIN; MALE; MICE; OXYNTOMODULIN; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-FOS; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON;

EID: 67651176104     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0796     Document Type: Article

References (45)

1. Tschöp M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
2. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
3. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR 2001 Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547
4. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D 2004 Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 287:E297-E304
5. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719
6. Tschöp M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C 2001 Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24:RC19-RC21
7. McCowen KC, Maykel JA, Bistrian BR, Ling PR 2002 Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J Endocrinol 175:R7-R11
8. Nakagawa E, Nagaya N, Okumura H, Enomoto M, Oya H, Ono F, Hosoda H, Kojima M, Kangawa K 2002 Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond) 103:325-328
9. Williams DL, Cummings DE, Grill HJ, Kaplan JM 2003 Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 144:2765-2767
10. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, Sherwin RS 2003 The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284:E313-E316
11. Möhlig M, Spranger J, Otto B, Ristow M, Tschöp M, Pfeiffer AF 2002 Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 25:RC36-RC38.
12. Saad MF, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R 2002 Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87:3997-4000
13. Briatore L, Andraghetti G, Cordera R 2003 Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. Eur J Endocrinol 149: 403-406
14. Caixás A, Bashore C, Nash W, Pi-Sunyer F, Laferrère B 2002 Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 87:1902
15. Gelling RW, Overduin J, Morrison CD, Morton GJ, Frayo RS, Cummings DE, Schwartz MW 2004 Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding. Endocrinology 145:4575-4582
16. Murdolo G, Lucidi P, Di Loreto C, Parlanti N, De Cicco A, Fatone C, Fanelli CG, Bolli GB, Santeusanio F, De Feo P 2003 Insulin is required for prandial ghrelin suppression in humans. Diabetes 52:2923-2927
17. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR 2003 Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941-948
18. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, Bloom SR 2003 Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88:4696-4701
19. Brennan IM, Otto B, Feltrin KL, Meyer JH, Horowitz M, Feinle-Bisset C 2007 Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides 28:607-611
20. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR 2004 Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145:2687-2695
21. Pérez-Tilve D, González-Matías L, Alvarez-Crespo M, Leiras R, Tovar S, Diéguez C, Mallo F 2007 Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes 56:143-151
22. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, Bloom SR 2001 Oxyntomodulin inhibits food intake in the rat. Endocrinology 142:4244-4250
23. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA, Bloom SR 1997 Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138:351-355
24. Hosoda H, Doi K, Nagaya N, Okumura H, Nakagawa E, Enomoto M, Ono F, Kangawa K 2004 Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem 50:1077-1080
25. Abbott CR, Kennedy AR, Wren AM, Rossi M, Murphy KG, Seal LJ, Todd JF, Ghatei MA, Small CJ, Bloom SR 2003 Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 144:3943-3949
26. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR 2000 Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone. Diabetes 49:177-182
27. Paxinos G, Watson C 1998 The rat brain in stereotaxic coordinates. New York: Academic Press.
28. Druce MR, Minnion JS, Field BC, Patel SR, Shilito JC, Tilby M, Beale KE, Murphy KG, Ghatei MA, Bloom SR 2009 Investigation of structure-activity relationships of oxyntomodulin (Oxm) using Oxm analogs. Endocrinology 150:1712-1722
29. le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR 2005 Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab 90:1068-1071
30. Patterson M, Murphy KG, le Roux CW, Ghatei MA, Bloom SR 2005 Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab 90:2205-2211
31. Kreymann B, Williams G, Ghatei MA, Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304
32. Bhogal R, Smith DM, Purkiss P, Bloom SR 1993 Molecular identification of binding sites for calcitonin gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: species variation and binding of truncated CGRP and IAPP. Endocrinology 133:2351-2361
33. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, Jorgensen JO 2002 Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 56:203-206
34. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML 2001 Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709
35. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ 2001 The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 25(Suppl 5):S63-S67
36. Larsen PJ, Tang-Christensen M, Jessop DS 1997 Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138:4445-4455
37. Baggio LL, Huang Q, Brown TJ, Drucker DJ 2004 Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127:546-558
38. Schjoldager BT, Baldissera FG, Mortensen PE, Holst JJ, Christiansen J 1988 Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 18:499-503
39. Ueno M, Carvalheira JB, Oliveira RL, Velloso LA, Saad MJ 2006 Circulating ghrelin concentrations are lowered by intracerebroventricular insulin. Diabetologia 49:2449-2452
40. Huo L, Gamber KM, Grill HJ, Bjørbaek C 2008 Divergent leptin signaling in proglucagon neurons of the nucleus of the solitary tract in mice and rats. Endocrinology 149:492-497
41. Erlanson-Albertsson C, Lindqvist A 2008 Vagotomy and accompanying pyloroplasty down-regulates ghrelin mRNA but does not affect ghrelin secretion. Regul Pept 151:14-18
42. Lee HM, Wang G, Englander EW, Kojima M, Greeley Jr GH 2002 Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143:185-190
43. Pekic S, Pesko P, Djurovic M, Miljic D, Doknic M, Glodic J, Dieguez C, Casanueva FF, Popovic V 2006 Plasma ghrelin levels of gastrectomized and vagotomized patients are not affected by glucose administration. Clin Endocrinol (Oxf) 64:684-688
44. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK 1998 Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21:1375-1385
45. Sim LJ, Joseph SA 1991 Arcuate nucleus projections to brainstem regions which modulate nociception. J Chem Neuroanat 4:97-109